Hormone Receptor Status and TN Stage Influence the Locoregional Benefit From Trastuzumab in Patients With HER 2–Positive Breast Cancer After Adjuvant Radiation Therapy

✍ Scribed by Cao, L.; Cai, G.; Yu, X.; Ma, J.; Yang, Z.; Shao, Z.; Guo, X.; Chen, J.

• Book ID: 126551090
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 72 KB
• Volume: 90
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2014.05.864